You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cagrilintide

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity Trial in Berlin (Cagrilintide, Cagrilintide Placebo, Moxifloxacin)

Not yet recruiting
  • Obesity
  • Cagrilintide
  • +3 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Mar 27, 2023

Hepatic Impairment Trial in München, Bratislava (Cagrilintide)

Not yet recruiting
  • Hepatic Impairment
  • Cagrilintide
  • München, Germany
  • +1 more
Nov 10, 2022

Obesity & Overweight Trial in Montreal, Søborg (Cagrilintide, semaglutide, Cagrilintide and semaglutide)

Completed
  • Obesity & Overweight
  • Cagrilintide
  • +2 more
  • Montreal, Quebec, Canada
  • +1 more
Mar 9, 2022

Obesity or Overweight Trial in China (Cagrilintide, Semaglutide, Placebo Semaglutide)

Not yet recruiting
  • Obesity or Overweight
  • Cagrilintide
  • +3 more
  • Beijing, Beijing, China
  • +24 more
Aug 10, 2023

Chronic Kidney Disease, Type 2 Diabetes, Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

Not yet recruiting
  • Chronic Kidney Disease
  • +2 more
  • Cagrilintide
  • +2 more
  • Concord, California
  • +73 more
Nov 9, 2023

Obesity or Overweight Trial in Japan, Taiwan (Cagrilintide, Semaglutide, Placebo Semaglutide)

Not yet recruiting
  • Obesity or Overweight
  • Cagrilintide
  • +2 more
  • Koriyama-shi, Fukushima, Japan, Japan
  • +21 more
Apr 3, 2023

Obesity Trial in United States (Cagrilintide, Semaglutide, Tirzepatide)

Not yet recruiting
  • Obesity
  • Cagrilintide
  • +2 more
  • Birmingham, Alabama
  • +44 more
Nov 9, 2023

Type 2 Diabetes Trial in Worldwide (Cagrilintide, Semaglutide, Placebo cagrilintide)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Cagrilintide
  • +3 more
  • Birmingham, Alabama
  • +331 more
Sep 26, 2023

Obesity Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Recruiting
  • Obesity
  • Cagrilintide
  • +3 more
  • Birmingham, Alabama
  • +225 more
Jan 24, 2023

Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Not yet recruiting
  • Overweight
  • +2 more
  • Cagrilintide
  • +3 more
  • Concord, California
  • +147 more
Jan 24, 2023

Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

Not yet recruiting
  • Obesity
  • Cagrilintide
  • +2 more
  • Birmingham, Alabama
  • +253 more
Jan 24, 2023